首页> Pediatric blood & cancer> Hydroxyurea for the treatment of sickle cell disease: Efficacy, barriers, toxicity, and management in children

Hydroxyurea for the treatment of sickle cell disease: Efficacy, barriers, toxicity, and management in children

导出原文传递

翻译打印收藏纠错

第一作者： Strouse,J.J.

作者： Strouse,J.J. ^[1] ; Heeney,M.M. ^[2]

作者单位： Division of Hematology/Oncology, Department of Medicine, Children's Hospital Boston, Boston, MA ^[1] Division of Pediatric Hematology, Department of Pediatrics, Johns Hopkins University School of ^[2]

关键词 Children Efficacy Hydroxyurea Sickle cell disease

发布时间 2013-11-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Pediatric blood & cancer

2012年59卷2期

365-371页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

点击下载本期目录封面

Pediatric blood & cancer

2012年59卷2期

365-371页

检索历史清除

Hydroxyurea for the treatment of sickle cell disease: Efficacy, barriers, toxicity, and management in children

Pediatric blood & cancer

相似文献

同项目论文

Pediatric blood & cancer

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Hydroxyurea for the treatment of sickle cell disease: Efficacy, barriers, toxicity, and management in children

Pediatric blood & cancer

相似文献

同项目论文

Pediatric blood & cancer

相关期刊

检索历史清除